Bal Pharma Balance Sheet Health

Financial Health criteria checks 3/6

Bal Pharma has a total shareholder equity of ₹692.6M and total debt of ₹1.4B, which brings its debt-to-equity ratio to 201.6%. Its total assets and total liabilities are ₹3.2B and ₹2.5B respectively. Bal Pharma's EBIT is ₹214.6M making its interest coverage ratio 1.4. It has cash and short-term investments of ₹200.5M.

Key information


Debt to equity ratio



Interest coverage ratio1.4x
Total liabilities₹2.51b
Total assets₹3.20b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 524824's short term assets (₹2.4B) exceed its short term liabilities (₹2.0B).

Long Term Liabilities: 524824's short term assets (₹2.4B) exceed its long term liabilities (₹472.2M).

Debt to Equity History and Analysis

Debt Level: 524824's net debt to equity ratio (172.7%) is considered high.

Reducing Debt: 524824's debt to equity ratio has reduced from 211.6% to 201.6% over the past 5 years.

Debt Coverage: 524824's debt is not well covered by operating cash flow (16.3%).

Interest Coverage: 524824's interest payments on its debt are not well covered by EBIT (1.4x coverage).

Balance Sheet

Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.